You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Surge in federal approvals buoys drug makers

SAN FRANCISCO — Something odd is going on in the pharmaceutical world: Though the industry is coping with a sluggish economy and bracing for federal cuts in medical research funding, the mood among the 8,000 executives at the industry’s premier investors conference is decidedly upbeat.

As the 31st annual J.P. Morgan Healthcare Conference got underway Monday, talk was about the pace of US drug approvals picking up after a relative dry spell. Last year, the Food and Drug Administration allowed 39 new treatments on the market, up from 30 in 2011 and the most in 16 years.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week